EASL International Liver Congress

Location: Vienna


Event description:

With 9000 delegates anticipated to attend and recognized as the "world’s greatest congress on the liver and hepatology", the EASL Congress 2023 present the perfect opportunity to connect on your hepatology program to discuss how you can leverage APAC, US or Europe for your global drug development plans in 2023 and beyond.

Novotech has robust relationships with investigators allowing to quickly identify the best sites for liver disease clinical studies. Over the last 25 years, Novotech has provided high-quality Liver disease CRO and drug development consulting services to numerous biotechnology companies using an approach adapted to the biotech model.

Schedule a meeting with our attendees


Novotech EU

David Chia

Novotech EU
Senior Business Development Manager
Novotech Australia

Thomas (Tom) Hickey

Novotech Australia
Team Lead Therapeutic Strategy

Plus Senior team members from our Novotech China, Client Operations, Novotech DDC and US and European BD teams